Effect of dehydroepiandrosterone on hereditary angioedema

Summary

Hereditary angioneurotic edema (HAE) is a complement-related clinical disorder with a deficiency of the C1 esterase inhibitor protein. Eight patients with severe attacks of the disease were treated with the adrenal “androgen” dehydroepiandrosterone sulphate (DS). Steroid therapy for 3–28 months resulted in dramatic improvement in their clinical state and a moderate increase in the serum concentration of C1 inhibitor. There was a significant increase in the serum level of either unconjugated dehydroepiandrosterone (D) or of DS during treatment.

This is a preview of subscription content, log in to check access.

References

  1. 1.

    Abraham GE, Buster JE, Kyle FW, Corrales PC, Teller RC (1973) Radioimmunoassay of plasma pregnenolone, 17-hydroxypregnenolone and dehydroepiandrosterone under various physiological conditions. J Clin Endocrinol Metab 37:140–144

    Google Scholar 

  2. 2.

    Bodrogi L, Fehér T (1982) Microfilter paper radioimmunoassay of cortisol and dehydroepiandrosterone sulphate in capillary blood. Radiochem Radioanal Letters 52:201–208

    Google Scholar 

  3. 3.

    Coleman DL, Leiter EH, Schwizer RW (1982) Therapeutic effects of dehydroepiandrosterone (DHEA) in diabetic mice. Diabetes 31:830–833

    Google Scholar 

  4. 4.

    Davis PJ, Fadis FB, Charache P (1974) Long-term therapy of hereditary angioedema (HAE): preventive management with fluoxymesterone and oxymetholone in severely affected males and females. Johns Hopkins Med J 135:391–398

    Google Scholar 

  5. 5.

    Donaldson VH, Evans RR (1960) A biochemical abnormality in hereditary angioneurotic edema. Am J Med 35:73–44

    Google Scholar 

  6. 6.

    Duck SC, Katayama KP (1981) Danazol may cause pseudohermaphroditism. Fertil Steril 35:230–231

    Google Scholar 

  7. 7.

    Frank MM (1979) Effect of sex hormones on the complement related clinical disorder of hereditary angioedema. Arthritis Rheum 22:1295–1299

    Google Scholar 

  8. 8.

    Gelfand JA, Sherins RJ, Alling DW, Frank MM (1976) Treatment of hereditary angioedema with danazol: reverse of clinical and biochemical abnormalities. N Engl J Med 295:1444–1448

    Google Scholar 

  9. 9.

    Hosea SW, Santaella ML, Brown EJ, Berger M, Katusha K, Frank MM (1980) Long-term therapy of hereditary angioedema with danazol. Ann Intern Med 93:809–812

    Google Scholar 

  10. 10.

    Hughes MJ, Rifkind AB (1981) Danazol, a new steroidal inducer ofδ-amino-levulinic acid synthetase. J Clin Endocrinol Metab 52:549–552

    Google Scholar 

  11. 11.

    Nelson RA, Jensen J, Gigli I, Tamura N (1966) Methods for the separation, purification and measurement of nine components of hemolytic complement in guinca pig scrum. Immunochem 3:111–135

    Google Scholar 

  12. 12.

    Rodbard D, Lewald JE (1970) Computer analysis of radioligand assay and radioimmunoassay data. Acta Endocrinol (Kbh) 64:79–103

    Google Scholar 

  13. 13.

    Spaulding WB (1960) Methyltestosterone therapy for hereditary episodic edema (hereditary angioneurotic edema). Ann Intern Med 53:739–745

    Google Scholar 

  14. 14.

    Tanner RM, Schwartz AG (1982) Reduced weight gain and delay of Coomb's positive hemolytic anemia in NZB mice treated with dehydroepiandrosterone (DHEA). Fed Proc 41:463

    Google Scholar 

  15. 15.

    Vogelaar EF, Brummelhuis HGJ, Krunen HW (1974) Contribution to the optimal use of human blood. Vox Sang 26:118–123

    Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Dr. E. Koó.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Koó, E., Fehér, K.G., Fehér, T. et al. Effect of dehydroepiandrosterone on hereditary angioedema. Klin Wochenschr 61, 715–717 (1983). https://doi.org/10.1007/BF01487618

Download citation

Key words

  • Hereditary angioedema
  • C1 esterase inhibitor deficiency
  • Dehydroepiandrosterone therapy